ArticleScientific reports2022

The combination of pre-neoadjuvant chemoradiotherapy inflammation biomarkers could be a prognostic marker for rectal cancer patients.

Jing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.